11/18/20 17:04 | 11/16/20 | ABBV | Abbvie Inc. | DE | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | Vice CB | M.d | 4,156 | 35.88 | 0 | 116 | 293 | 155 | D | | | | | | | | | | | | | | |
11/18/20 17:04 | 11/16/20 | ABBV | Abbvie Inc. | DE | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | Vice CB | S.d | -11,583 | 100.00 | 0 | -116 | -43 | 155 | D | | | | | | | | | | | | | | |
7/8/20 21:19 | 7/7/20 | ABBV | Abbvie Inc. | DE | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | Vice CB | S | -5,333 | 100.00 | 0 | -53 | -26 | 155 | D | | | | | | | | | | | | | | |
3/2/18 17:29 | 2/28/18 | ABBV | Abbvie Inc. | DE | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | EVP,Comm | S.dm | -9,569 | 114.49 | 0 | -84 | -38 | 138 | D | | | | | | | | | | | | | | |
3/2/18 17:29 | 3/1/18 | ABBV | Abbvie Inc. | DE | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | EVP,Comm | M.d | 1,406 | 29.23 | 0 | 48 | 54 | 138 | D | | | | | | | | | | | | | | |
6/15/17 17:05 | 6/14/17 | ABBV | Abbvie Inc. | DE | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | EVP,Comm | M.d | 1,109 | 24.21 | 0 | 46 | 42 | 155 | D | | | | | | | | | | | | | | |
6/15/17 17:05 | 6/14/17 | ABBV | Abbvie Inc. | DE | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | EVP,Comm | S.d | -3,206 | 70.00 | 0 | -46 | -23 | 155 | D | | | | | | | | | | | | | | |
5/8/17 17:13 | 5/4/17 | ABBV | Abbvie Inc. | DE | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | EVP,Comm | S | -2,881 | 67.00 | 33 | -43 | -22 | 155 | D | 13 | 12 | 20 | 12 | 3 | 4 | 3 | 1 | 0 | 0 | | | | |
5/12/16 17:39 | 5/10/16 | ABBV | Abbvie Inc. | DE | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | EVP,Comm | S | -3,013 | 63.52 | 33 | -47 | -20 | 190 | D | 28 | 0 | 1 | 20 | 11 | 2 | 2 | 0 | -1 | -3 | -2 | 7 | -4 | |
3/4/14 17:10 | 3/3/14 | ABBV | Abbvie Inc. | DE | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | EVP,Comm | S | -144 | 50.09 | 33 | -3 | -1 | 246 | D | | 37 | 20 | 5 | 0 | 1 | -3 | -1 | 0 | 0 | 1 | 6 | 9 | 20 |
5/3/13 17:27 | 5/1/13 | ABBV | Abbvie Inc. | DE | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | EVP,Comm | M.d | 3,994 | 27.95 | 33 | 143 | 194 | 217 | D | | | | 21 | 15 | 2 | -3 | -3 | 0 | -1 | -3 | 2 | 11 | 19 |
5/3/13 17:27 | 5/1/13 | ABBV | Abbvie Inc. | DE | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | EVP,Comm | S.d | -5,191 | 45.68 | 33 | -114 | -34 | 217 | D | | | | 21 | 15 | 2 | -3 | -3 | 0 | -1 | -3 | 2 | 11 | 19 |
2/7/13 16:44 | 2/5/13 | ABBV | Abbvie Inc. | DE | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | EVP,Comm | M.d | 84 | 33.80 | 33 | 2 | 2 | 153 | D | | | | | | 5 | 1 | 0 | -1 | -3 | 2 | 20 | 24 | 36 |
9/27/12 17:10 | 9/25/12 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | M.d | 69 | 57.25 | 33 | 1 | 1 | 115 | D | 42 | 40 | 15 | 11 | 4 | 3 | 0 | -1 | -1 | 1 | -4 | -6 | 10 | 2 |
9/27/12 17:10 | 9/25/12 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | S.d | -84 | 70.00 | 33 | -1 | -1 | 115 | D | 42 | 40 | 15 | 11 | 4 | 3 | 0 | -1 | -1 | 1 | -4 | -6 | 10 | 2 |
9/21/12 17:09 | 9/20/12 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | M.d | 109 | 56.98 | 33 | 2 | 2 | 115 | D | 44 | 40 | 18 | 13 | 6 | 7 | 4 | 1 | 0 | 0 | -4 | -4 | 4 | 5 |
9/21/12 17:09 | 9/20/12 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | S.d | -134 | 69.75 | 33 | -2 | -2 | 115 | D | 44 | 40 | 18 | 13 | 6 | 7 | 4 | 1 | 0 | 0 | -4 | -4 | 4 | 5 |
9/17/12 17:06 | 9/13/12 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | M.d | 75 | 56.00 | 33 | 1 | 1 | 115 | D | 42 | 38 | 17 | 10 | 3 | 4 | 4 | 1 | 0 | 1 | 5 | -5 | 3 | 10 |
9/17/12 17:06 | 9/13/12 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | S.d | -92 | 68.75 | 33 | -1 | -1 | 115 | D | 42 | 38 | 17 | 10 | 3 | 4 | 4 | 1 | 0 | 1 | 5 | -5 | 3 | 10 |
8/1/12 17:29 | 7/30/12 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | S | -23 | 66.62 | 33 | 0 | 0 | 115 | D | 43 | 36 | 24 | 7 | 6 | 2 | 2 | 3 | 0 | 0 | -1 | 0 | 8 | 18 |
7/30/12 17:05 | 7/27/12 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | M.d | 1,933 | 43.11 | 33 | 45 | 64 | 115 | D | 45 | 33 | 23 | 8 | 7 | 2 | 1 | 4 | 0 | 0 | -1 | -1 | 5 | 17 |
7/30/12 17:05 | 7/27/12 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | S.d | -2,916 | 65.03 | 33 | -45 | -28 | 115 | D | 45 | 33 | 23 | 8 | 7 | 2 | 1 | 4 | 0 | 0 | -1 | -1 | 5 | 17 |
7/25/12 17:39 | 7/23/12 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | M.d | 266 | 48.92 | 33 | 5 | 5 | 115 | D | 39 | 26 | 16 | 6 | 4 | -1 | -2 | -3 | 1 | 3 | 2 | 3 | 8 | 22 |
3/22/12 17:17 | 3/20/12 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | S | -50 | 60.22 | 33 | -1 | -1 | 114 | I | 19 | 31 | 16 | 12 | 9 | 5 | 4 | 2 | 0 | 2 | 0 | 5 | 17 | 20 |
3/2/12 17:20 | 2/29/12 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | S | -68 | 56.71 | 33 | -1 | -1 | 115 | D | 14 | 25 | 13 | 9 | 3 | 4 | 2 | 1 | 0 | 0 | 7 | 9 | 16 | 29 |
12/23/11 17:24 | 12/21/11 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | M.d | 257 | 53.63 | 33 | 5 | 5 | 94 | D | 10 | 21 | 10 | 10 | 3 | 3 | 2 | 2 | 0 | 0 | -1 | 10 | 13 | 20 |
12/23/11 17:24 | 12/21/11 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | S.d | -263 | 55.00 | 33 | -5 | -5 | 94 | D | 10 | 21 | 10 | 10 | 3 | 3 | 2 | 2 | 0 | 0 | -1 | 10 | 13 | 20 |
3/2/11 17:04 | 2/28/11 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | S | -456 | 48.00 | 33 | -9 | -9 | 91 | D | 8 | -10 | -2 | 3 | 1 | 4 | 3 | 1 | 1 | 2 | 3 | 11 | 9 | 23 |
2/3/11 17:25 | 2/1/11 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | S | -131 | 45.27 | 33 | -3 | -4 | 67 | D | -14 | -13 | -7 | -9 | -4 | -4 | -5 | 1 | 0 | -1 | 6 | 16 | 11 | 23 |
3/2/10 18:53 | 3/1/10 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | S | -722 | 54.42 | 33 | -13 | -17 | 66 | D | 6 | 19 | 18 | 1 | -2 | 2 | -1 | 0 | -1 | 0 | -4 | -12 | -7 | -9 |
2/23/10 20:46 | 2/16/10 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | S.a | -65 | 53.94 | 33 | -1 | -4 | 29 | D | 5 | 4 | 22 | 3 | 0 | 2 | 2 | -1 | 1 | 1 | 1 | -12 | -7 | -10 |
2/18/10 18:20 | 2/16/10 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | S | -65 | 53.94 | 33 | -1 | -4 | 29 | D | 5 | 5 | 24 | 4 | 2 | 2 | 1 | 2 | -1 | -1 | -2 | -12 | -6 | -12 |
2/12/10 17:08 | 2/10/10 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | M.d | 88 | 49.23 | 33 | 2 | 9 | 22 | D | 2 | -1 | 24 | 2 | -1 | -2 | -2 | 0 | 1 | 1 | 2 | -9 | -5 | -13 |
2/12/10 17:08 | 2/10/10 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | S.d | -95 | 53.20 | 33 | -2 | -8 | 22 | D | 2 | -1 | 24 | 2 | -1 | -2 | -2 | 0 | 1 | 1 | 2 | -9 | -5 | -13 |
11/4/09 17:05 | 11/2/09 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Alban Carlos | IL | O | SVP | S | -255 | 50.95 | 33 | -5 | -19 | 22 | D | -1 | -7 | 19 | 16 | 10 | -2 | -2 | -1 | 1 | 4 | 7 | 7 | -2 | 4 |